// App-Quantinova.ai

: Long-term Follow-up of CD20-directed Chimeric Antigen Receptor Adoptive T-cell Therapy

Researchers

Presenter

  • George Mo

Principal Investigators

  • Sang Yun Lee

  • David G. Coffey

  • Valentin Voillet

  • IIan Kirsch

  • Damian J. Green

  • Raphael Gottardo

  • David G. Maloney

  • Oliver W. Press

  • Brian G. Till

Medical Centers

  • University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland

  • Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

  • University of Miami, Miami, FL

  • Department of Medicine, University of Washington, Seattle, WA

  • Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa

  • Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA

Locations

  • Switzerland

  • South Africa

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Alpha-thalassemia myelodysplasia syndrome

  • Mantle cell lymphoma

  • Follicular lymphoma

  • Hodgkin's Lymphoma

  • B cell lymphomas

  • Solid malignancies

  • Non‐Hodgkin Lymphoma

  • Lymphomas

Biomarkers

  • Peripheral blood mononuclear cell

  • Interferon-gamma

  • Immunoglobulin G

  • Interleukin-2

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • fludarabine tablet

  • Interferon Gamma

  • IFN-lambda

Outcome

  • N/A

Study Design

  • Adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved